Of note, under minimized log-rank p values, we found that the majority (66.3%) of TCGA oral cancer patients, but not nonoral cancer patients, harbored higher NEDD8 expression and had shorter overall and progression-free survival times (Fig. 1E). This evidence concerns the gene NEDD8 and cancer.